Form 4 for LFCR LIFECORE BIOMEDICAL, INC. DE
Accepted 2023-01-24 00:00:00 ET · period of report 2023-01-20 · accession 0001628280-23-001478 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-24 | 2023-01-20 | LFCR | Diradoorian Raymond H | Dir | A - Grant | $7.00 | +2,768 | 2,768 | New | +$19.4K |
| D | 2023-01-24 | 2023-01-20 | LFCR | Diradoorian Raymond H | Dir | M - OptEx | $7.00 | -2,768 | 0 | -100% | -$19.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-20 | A | A | 2,768 | $7.00 | 2,768 | D | — | — | (F1) The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. |
| 2 | Derivative | Restricted Stock Unit | 2023-01-20 | M | D | 2,768 | $7.00 | 0 | D | — · 2023-01-20 to — | 2,768 Common Stock | (F2) The restricted stock units were granted on January 20, 2022. (F1) The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. (F3) The restricted stock units vested on January 20, 2023. |